| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating costs and expenses | ||||||||
Research and development | ||||||||
647 | 1,011 | 490 | 388 | 134 | 227 | 299 | 216 | 41 |
Research and development - licenses acquired (including stock-based compensation) | ||||||||
39 | 25 | 50 | 10 | 10 | 0 | 66 | 32 | 132 |
Compensation and related expenses (including stock-based compensation) | ||||||||
165 | 2,141 | 336 | 133 | 321 | 93 | 96 | 210 | 109 |
Professional fees (including stock-based compensation) | ||||||||
806 | 610 | 643 | 544 | 293 | 153 | 107 | 229 | 192 |
Rent | ||||||||
8 | 8 | 8 | 8 | 7 | 7 | 8 | 6 | 6 |
Other expenses | ||||||||
149 | 122 | 171 | 182 | 62 | 101 | 41 | 68 | 46 |
Total operating expenses | ||||||||
1,816 | 3,917 | 1,700 | 1,267 | 829 | 584 | 620 | 763 | 527 |
Loss from operations | ||||||||
-1,816 | -3,917 | -1,700 | -1,267 | -829 | -584 | -620 | -763 | -527 |
Other expenses | ||||||||
Other expense, net | ||||||||
-10 | - | 4 | - | - | - | - | - | - |
Total other expenses | ||||||||
-10 | - | 4 | - | - | - | - | - | - |
Net loss | ||||||||
-1,826 | - | - | - | -829 | - | - | - | - |
Net loss | ||||||||
- | - | -1,696 | -1,267 | - | -584 | -620 | -763 | -527 |
Weighted average number of common shares outstanding, basic and diluted | ||||||||
10,251 | 10,161 | 9,886 | 9,603 | 7,007 | 5,072 | 5,079 | 5,039 | 4,932 |
Net loss per share, basic and diluted | ||||||||
-0.18 | -0.42 | -0.17 | -0.13 | -0.12 | -0.12 | -0.12 | -0.15 | -0.11 |